Company profile: NorthSea Therapeutics
1.1 - Company Overview
Company description
- Provider of first-in-class, oral, structurally engineered lipid therapeutics leveraging Structurally Engineered Fatty Acid (SEFA) technology to target metabolic, inflammatory and fibrotic diseases. Pipeline includes Icosabutate (Phase 2b for NASH), SEFA-1024 (Phase 1 for severe hypertriglyceridemia), and SEFA-6179 (Phase 1 for intestinal failure-associated liver disease).
Products and services
- SEFA-1024: An oral, lipophilic SEFA targeting the gut-liver axis, in Phase 1 trial for severe hypertriglyceridemia treatment
- SEFA-6179: An oral, synthetic medium chain fatty acid analogue in Phase 1 trial for intestinal failure-associated liver disease
- Icosabutate: An oral, structurally-engineered SEFA in Phase 2b trial for NASH, showing improvements in liver function, inflammatory and fibrotic biomarkers, lipid profile, and glycemic control
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NorthSea Therapeutics
Hycor Biomedical
HQ: United States
Website
- Description: Provider of diagnostic systems and assays for allergy and mast cell activation, including NOVEOS for allergy testing with small sample volumes; NOVEOS assay reagents, consumables, and supplies for specific IgE tests; a Tryptase Assay chemiluminescent microparticle immunoassay for serum tryptase detection; and TASSO+, a capillary blood collection device compatible with NOVEOS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hycor Biomedical company profile →
Medac Pharma
HQ: United States
Website
- Description: Provider of healthcare products for rare diseases across rheumatology, auto-immune conditions, pediatrics, and specialty oncology. Offers therapies such as methotrexate formulations (Rasuvo auto-injector, Metoject pre-filled syringe) for rheumatoid arthritis and other auto-immune diseases; Rupall for allergies; IXINITY for Hemophilia B; Gleolan for glioma imaging; Trecondyv for transplant conditioning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medac Pharma company profile →
Kither Biotech
HQ: Italy
Website
- Description: Provider of pharmaceutical drug development targeting chronic inflammatory diseases, with inhaled therapies such as KIT2014, a cAMP-modulating peptide add-on for cystic fibrosis that enhances CFTR function, reduces mucus, and limits airway inflammation, and KITCL27, an inhaled PI3K-inhibitor prodrug for idiopathic pulmonary fibrosis activated in target cells to minimize systemic side effects.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kither Biotech company profile →
Aditxt
HQ: United States
Website
- Description: Provider of biotechnology solutions using novel nucleic acid-based technologies, including AditxtScore for personalized immune profiling; Apoptotic DNA Immunotherapy (ADI) to induce immune tolerance for transplants, autoimmune diseases, and allergies; Adimune for restoring immune tolerance; Pearsanta for personalized diagnostic and monitoring services; and Adivir developing medicines, diagnostics, and vaccines for public health threats.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aditxt company profile →
Sparrow Pharmaceuticals
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical therapies for disorders of corticosteroid excess, including SPI-62, an oral HSD-1 inhibitor designed to reduce intracellular cortisol in conditions like endogenous Cushing’s syndrome and autonomous cortisol secretion, and SPI-47, combining SPI-62 with prednisolone for autoimmune diseases such as polymyalgia rheumatica.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sparrow Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NorthSea Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NorthSea Therapeutics
2.2 - Growth funds investing in similar companies to NorthSea Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NorthSea Therapeutics
4.2 - Public trading comparable groups for NorthSea Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →